CSU has a new cancer study for dogs!

Posted By elaine on August 25, 2009

A study at Colorado State University’s Animal Cancer Center is looking at a new way to treat cancer in animals and people. The study is investigating the impact of a drug on cells that suppress the immune system and allow cancer tumors to grow. Initial results in mice and dogs show that the drug can reverse suppression of the immune system and halt tumor growth in dogs and, in some cases, even shrink tumors.
Baggins and I before he was diagnosed with MH

Baggins and I before he was diagnosed with MH

The team is looking for dogs with soft tissue sarcomas and malignant histiocytosis, called MH, to enroll in the clinical trial. Dogs with MH are often given a prognosis of only two to three months without treatment. These tumors are highly resistant to chemotherapy, and other options for treatment are limited.

This is a disease that is pretty near and dear to my heart. I lost my dog Baggins to this very disease three years ago. At that time there was no hope and all I could do is send tissue samples in hopes that one day it could be cured. I hope you never need this information, but if you do here is what you need to know.

Dogs that meet certain criteria can be enrolled in the studies. The soft tissue sarcoma study pays $500 toward the cost of treatment, such as surgery, at the end of the study. The study consists of six treatments over a time frame that ranges seven to 13 weeks, depending upon the treatment option that is selected. Dogs enrolled in the MH study are eligible to receive the drug at no cost, though all other charges are supported by the owners.

To discuss opportunities to enroll in the study, contact the Animal Cancer Center at 970-491-4535 and talk to Dr. Scott Hafeman.


Share this Post[?]

About The Author



Leave a Reply

Spam Protection by WP-SpamFree